OMX Stockholm PI
|
1 016,64
|
7,50
|
0,74 %
|
Analysen zu OMX Stockholm PI-Werten
| 24.03.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 18.03.25 | Volvo AB Buy | Deutsche Bank AG | |
| 17.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 17.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.03.25 | AstraZeneca Buy | UBS AG | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.03.25 | Volvo AB Sector Perform | RBC Capital Markets | |
| 13.03.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 12.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 07.03.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 04.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.03.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 28.02.25 | Volvo AB Buy | Deutsche Bank AG | |
| 27.02.25 | ABB Hold | Jefferies & Company Inc. | |
| 26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.02.25 | Volvo AB Buy | UBS AG | |
| 25.02.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
| 24.02.25 | ABB Neutral | UBS AG | |
| 24.02.25 | ABB Sector Perform | RBC Capital Markets | |
| 24.02.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 24.02.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 20.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 20.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 20.02.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 18.02.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 13.02.25 | AstraZeneca Buy | UBS AG | |
| 12.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 12.02.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 11.02.25 | ABB Underperform | Bernstein Research | |
| 11.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 11.02.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 10.02.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | AstraZeneca Halten | DZ BANK | |
| 07.02.25 | ABB Kaufen | DZ BANK |